Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
GLUE:NASDAQ
Monte Rosa Therapeutics Inc
$20.17
-3.86%
(-0.81) 1D
$20.23
+0.30% (+0.060)
Pre-market
Closed: Apr 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLUE...
Open
$20.87
High
$21.23
Low
$19.66
Mkt. cap
1.61B
Avg. vol.
1.21M
Volume
2.01K
52-wk high
$25.77
52-wk low
$3.51
EPS
-$0.46
Beta
1.64
Shares outstanding
80.02M
No. of employees
150
News stories
From sources across the web
About Monte Rosa Therapeutics Inc
CEO-
Employees150
Founded2019
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Last report
Mar 17, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.55/ (-0.34 est.)USD
-63.38%miss
Revenue / Estimate
2.78M/ (15.51M est.)USD
-82.07%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
84.93M
23.19M
12.77M
2.78M
Cost of goods sold
30.11M
29.04M
34.65M
39.89M
Cost of revenue
30.11M
29.04M
34.65M
39.89M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.78M
9.70M
11.09M
12.60M
Operating expense
10.78M
9.70M
11.09M
12.60M
Total operating expenses
40.89M
38.75M
45.74M
52.50M
Operating income
44.04M
-15.55M
-32.98M
-49.72M
Other non operating income
-
-
-
-
EBT including unusual items
47.71M
-11.10M
-30.26M
-46.08M
EBT excluding unusual items
47.65M
-11.10M
-30.26M
-46.08M
Income tax expense
822.00K
1.20M
-3.18M
59.00K
Effective tax rate
1.72%
-10.81%
10.50%
-0.13%
Other operating expenses
-
-
-
-
Net income
46.88M
-12.30M
-27.08M
-46.14M
Net profit margin
55.20%
-53.01%
-212.10%
-1,658.94%
Earnings per share
0.57
-0.15
-0.33
-0.55
Interest and investment income
3.44M
3.07M
2.75M
3.69M
Interest expense
-
-
-
-
Net interest expenses
3.44M
3.07M
2.75M
3.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
46.08M
-13.43M
-30.88M
-47.63M
Gain or loss from assets sale
-59.00K
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more